COVID-19-neutralizing antibodies predict disease severity and survival
- 15 December 2020
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 184 (2), 476-488.e11
- https://doi.org/10.1016/j.cell.2020.12.015
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts General Hospital
- Charles H. Hood Foundation
- Gilead Sciences
- National Institutes of Health
This publication has 71 references indexed in Scilit:
- Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in SerumClinical and Vaccine Immunology, 2010
- Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodiesBiochemical and Biophysical Research Communications, 2010
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entryVirology Journal, 2009
- The Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains a Novel Endoplasmic Reticulum Retrieval Signal That Binds COPI and Promotes Interaction with Membrane ProteinJournal of Virology, 2007
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLoS Medicine, 2006
- Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63Clinical and Vaccine Immunology, 2005
- Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2Journal of Virology, 2004
- Immunogenicity and protective efficacy of influenza vaccinationVirus Research, 2004
- Intracellular Targeting Signals Contribute to Localization of Coronavirus Spike Proteins near the Virus Assembly SiteJournal of Virology, 2004